AROUND THE INDUSTRY
Striving to become more patient-centric in life sciences.
Deloitte recommends harness[ing] digital and data analytics opportunities to engage patients, improve their experience, and collect data on outcomes and unmet needs Read More …
AROUND THE INDUSTRY
MyOwnMed legal counsel, Goodwin Procter: The impact COVID-19 may have on our life sciences clients
“As the COVID-19 pandemic unfolds, our drug, biologic, and medical device clients conducting or planning to conduct clinical trials may be faced with challenges related to quarantines, travel limitations, site closures or access restrictions, infection transmission concerns of site research personnel and study subjects, and supply chain interruptions.” Read More Read more…
AROUND THE INDUSTRY
US FDA Outlines Wishlist For Decentralized Clinical Trials
Clinical Trial Sponsors Should Consider Changing Data Collection Amid COVID-19, US FDA Says. (March 18, 2020) READ MORE …